New Key Statistics Module, Z-Score and F-Score
NAS:ADAP Key Ratios
| Market Cap $ M | 276.01 |
| Enterprise Value $ M | 164.53 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 6.35 |
| Price/Sales | 3.24 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 60.00 |
| EPS (TTM) $ | -0.47 |
| Beneish M-Score | -1.34 |
| 10-y EBITDA Growth Rate % | -34.40 |
| 5-y EBITDA Growth Rate % | 4.40 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.19 |
| EV-to-EBITDA | -1.28 |
| PEG | -- |
| Shares Outstanding M | 255.56 |
| Net Margin (%) | -188.90 |
| Operating Margin % | -228.99 |
| Pre-tax Margin (%) | -186.68 |
| Quick Ratio | 2.85 |
| Current Ratio | 2.85 |
| ROA % (ttm) | -36.99 |
| ROE % (ttm) | -135.55 |
| ROIC % (ttm) | -128.07 |
| Dividend Yield % | -- |
| Altman Z-Score | -4.89 |
ADAP Number of Guru Trades
ADAP Volume of Guru Trades
Gurus Latest Trades with NAS:ADAP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ADAP is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Adaptimmune Therapeutics PLC Insider Transactions
No Available Data
News about NAS:ADAP
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers